United States: Yearly Stock Market Performance Insight - 2006

You are viewing United States market data. Switch to:
🇺🇸 United States ✓ 🇮🇳 India 🇫🇷 France 🌐 Belgium 🌐 Netherlands 🇵🇹 Portugal 🇪🇸 Spain
Yearly Gainers
1,456
Yearly Losers
564
Average Return
99.64%
Total Stocks
2,120
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 29 7 18.59% 37
Large Cap 388 94 20.25% 492
Mid Cap 345 121 23.54% 486
Small Cap 134 46 25.87% 190
Overview Top Gainers/Losers Most Active Sector Performance

Yearly Streak Leaders for 2006

Stock Streak Streak Return
6 years ↑ 64.54%

Procter & Gamble continues its impressive multi-year expansion with a 6-year growth streak (39.06 → 64.27), delivering 64.5% cumulative returns. Annual financials validate this performance: 19.8B revenue generating 3.8B net profit (19.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.
5 years ↑ 63.95%

Wells Fargo demonstrates exceptional long-term growth with a 5-year growth streak (21.69 → 35.56), delivering 63.9% cumulative returns. With 20.1B annual revenue generating only 4.8B profit (23.8% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.
3 years ↓ -26.46%

Eli Lilly and sees continued yearly losses with a 3-year decline (70.85 → 52.10), down 26.5% cumulatively. Yet fundamentals remain solid: 12.7B annual revenue generating 2.8B profit (21.7% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.
3 years ↓ -13.44%

Walmart encounters consecutive annual declines with a 3-year decline (17.78 → 15.39), down 13.4% cumulatively. Weak margins on 165.6B annual revenue with only 4.6B profit (2.8% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.
13 years ↑ 4,208.51%

Expeditors continues its impressive multi-year expansion with a 13-year growth streak (0.94 → 40.50), delivering 4,208.5% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.
11 years ↑ 4,204.40%

Pool demonstrates exceptional long-term growth with a 11-year growth streak (0.91 → 39.17), delivering 4,204.4% cumulative returns. With 1.1B annual revenue generating only 53.5M profit (5.0% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.
5 years ↓ -82.25%

Tenet Healthcare struggles through multi-year headwinds with a 5-year decline (157.07 → 27.88), down 82.2% cumulatively. Weak margins on 5.2B annual revenue with only 622.0M profit (11.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.
3 years ↓ -70.57%

Insmed encounters consecutive annual declines with a 3-year decline (29.90 → 8.80), down 70.6% cumulatively. Financial struggles compound yearly losses: despite 92.8M annual revenue, - 256.6M losses persist (-276.4% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.
10 years ↑ 2,765.09%

Oshkosh demonstrates exceptional long-term growth with a 10-year growth streak (1.69 → 48.42), delivering 2,765.1% cumulative returns. With 2.3B annual revenue generating only 112.2M profit (4.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.
8 years ↑ 3,695.06%

Ssr Mining continues its impressive multi-year expansion with a 8-year growth streak (0.81 → 30.74), delivering 3,695.1% cumulative returns. Annual financials validate this performance: 316.6M revenue generating 54.4M net profit (17.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.
3 years ↓ -80.86%

Kratos Defense navigates difficult years with a 3-year decline (148.90 → 28.50), down 80.9% cumulatively. Weak margins on 302.6M annual revenue with only 4.5M profit (1.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.
3 years ↓ -72.44%

Sanmina navigates difficult years with a 3-year decline (75.12 → 20.70), down 72.4% cumulatively. Weak margins on 2.0B annual revenue with only 70.5M profit (3.6% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.
7 years ↑ 1,297.14%

Pediatrix Medical demonstrates exceptional long-term growth with a 7-year growth streak (1.75 → 24.45), delivering 1,297.1% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.
7 years ↑ 951.43%

National Healthcare demonstrates exceptional long-term growth with a 7-year growth streak (5.25 → 55.20), delivering 951.4% cumulative returns. With 373.7M annual revenue generating only 32.3M profit (8.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.
4 years ↓ -50.91%

La-Z-Boy struggles through multi-year headwinds with a 4-year decline (24.18 → 11.87), down 50.9% cumulatively. Weak margins on 570.9M annual revenue with only 15.4M profit (2.7% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.
3 years ↓ -51.09%

Celldex Therapeutics encounters consecutive annual declines with a 3-year decline (493.20 → 241.20), down 51.1% cumulatively. Financial struggles compound yearly losses: despite 695,000 annual revenue, - 53.8M losses persist (-7740.4% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

United States Market Yearly Gainers & Losers: 2006

Top United States Stock Gainers (2006)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.31 $0.62 106.67% 611.3M 154.1B
$17.21 $27.33 59.64% 52.6M 13.2B
$18.50 $27.00 45.95% 24.3M 6.1B
$57.17 $81.43 43.51% 4.2M 1.1B
$23.75 $33.81 42.96% 10.6M 2.7B
$7.30 $21.58 196.84% 8.2M 2.1B
$7.12 $19.66 178.87% 2.0M 499.3M
$20.00 $53.12 166.53% 4.0M 1.0B
$36.40 $90.68 151.33% 3.0M 751.2M
$39.72 $89.48 126.70% 2.1M 539.1M
$0.62 $4.62 755.56% 119.4K 30.1M
$1.82 $8.05 342.31% 217.2K 54.7M
$2.11 $7.93 275.83% 451.9K 113.9M
$5.20 $18.74 272.56% 22.0K 5.6M
$2.00 $6.49 224.50% 1.2K 304.0K
$2.35 $7.75 236.96% 63.7K 16.1M
$6.25 $17.45 179.65% 229.6K 57.8M
$5.49 $14.83 175.65% 96.0K 24.2M
$2.35 $5.62 137.13% 65.5K 16.5M
$4.55 $10.19 132.65% 76.3K 19.2M

Biggest United States Stock Losers (2006)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$31.02 $20.35 -33.50% 19.2M 4.8B
$2.37 $1.97 -16.53% 142.2M 35.8B
$62.60 $53.73 -13.53% 8.2M 2.1B
$57.19 $52.10 -7.93% 4.0M 1.0B
$3.87 $3.69 -4.65% 9.4M 2.4B
$63.35 $10.42 -83.39% 1.5M 389.6M
$19.80 $8.80 -54.17% 159.1K 40.1M
$33.66 $18.47 -44.37% 472.8K 119.2M
$6.60 $4.08 -37.04% 3.9K 984.5K
$3.75 $2.46 -34.05% 1.6M 409.0M
$3.65 $1.23 -66.30% 135.7K 34.2M
$30.04 $13.84 -54.11% 66.7K 16.8M
$18.50 $9.02 -51.27% 92.1K 23.2M
$2.48 $1.30 -47.58% 14.3K 3.6M
$68.10 $35.40 -47.16% 4.2M 1.1B
$7.18 $3.76 -46.74% 642.4K 161.9M
$1.68 $0.98 -41.67% 2.4K 598.5K
$3.39 $2.16 -37.57% 27.3K 6.9M
$22.71 $14.91 -34.52% 250.5K 63.1M
$18.57 $12.25 -33.68% 59.0K 14.9M

Most Active United States Stocks During 2006

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$2.59 $3.03 17.90% 855.9M 215.7B
$0.31 $0.62 106.67% 611.3M 154.1B
$10.57 $11.52 10.98% 338.0M 85.2B
$2.37 $1.97 -16.53% 142.2M 35.8B
$26.25 $29.86 14.19% 66.8M 16.8B
$25.19 $20.25 -18.87% 70.6M 17.8B
$1.68 $2.81 71.34% 68.4M 17.2B
$18.40 $12.66 -30.40% 40.0M 10.1B
$2.83 $3.83 35.82% 37.4M 9.4B
$7.72 $7.51 -2.72% 33.6M 8.5B
$22.20 $42.59 93.59% 17.2M 4.3B
$4.40 $5.80 31.52% 16.3M 4.1B
$7.04 $9.26 31.35% 10.2M 2.6B
$10.83 $9.48 -11.73% 10.1M 2.5B
$4.65 $6.31 31.73% 7.3M 1.8B
$23.74 $15.91 -32.56% 6.8M 1.7B
$5.06 $7.47 47.92% 5.1M 1.3B
$14.72 $14.20 -7.67% 4.8M 1.2B
$15.52 $31.21 103.72% 4.2M 1.1B
$6.92 $10.67 55.99% 2.2M 554.1M

United States Sector Performance During 2006

Healthcare

423.57%
259 stocks
Top Performers by Market Cap:
Mega Cap: ABT +23.52%
Large Cap: ILMN +178.87%
Mid Cap: RDNT +755.56%
Small Cap: UFPT +137.13%

Basic Materials

38.13%
123 stocks
Top Performers by Market Cap:
Mega Cap: LIN +12.03%
Large Cap: AEM +108.70%
Mid Cap: HBM +272.56%
Small Cap: MTRN +112.39%

Real Estate

28.50%
112 stocks
Top Performers by Market Cap:
Large Cap: EQIX +85.53%
Mid Cap: SBRA +91.07%
Small Cap: ALX +70.94%

Communication Services

28.12%
71 stocks
Top Performers by Market Cap:
Mega Cap: T +45.95%
Large Cap: LYV +70.99%
Mid Cap: CCOI +195.45%
Small Cap: LGF.A +39.71%

Industrials

25.09%
340 stocks
Top Performers by Market Cap:
Mega Cap: GE +6.17%
Large Cap: ATI +151.33%
Mid Cap: AGX +224.50%
Small Cap: GIC +179.65%

Consumer Defensive

21.89%
101 stocks
Top Performers by Market Cap:
Mega Cap: KO +19.64%
Large Cap: MNST +71.34%
Mid Cap: PSMT +114.23%
Small Cap: ANDE +96.80%

Technology

19.61%
281 stocks
Top Performers by Market Cap:
Mega Cap: NVDA +106.67%
Large Cap: AKAM +166.53%
Mid Cap: BB +93.59%
Small Cap: CNXN +175.65%

Energy

19.12%
94 stocks
Top Performers by Market Cap:
Mega Cap: XOM +36.43%
Large Cap: OKE +61.92%
Mid Cap: DINO +74.59%
Small Cap: DNN +132.65%

Financial Services

18.63%
408 stocks
Top Performers by Market Cap:
Mega Cap: MS +43.51%
Large Cap: ICE +196.84%
Mid Cap: CRVL +275.83%
Small Cap: WT +236.96%

Utilities

16.93%
61 stocks
Top Performers by Market Cap:
Large Cap: ES +43.02%
Mid Cap: OGE +49.25%
Small Cap: SJW +70.37%

Consumer Cyclical

16.70%
248 stocks
Top Performers by Market Cap:
Mega Cap: MCD +31.47%
Large Cap: LVS +126.70%
Mid Cap: SKX +117.22%
Small Cap: AEO +103.72%

Data is updated regularly. Yearly performance is calculated based on closing prices.